208 related articles for article (PubMed ID: 23353590)
1. β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.
Abbas MA; Taha MO; Zihlif MA; Disi AM
Eur J Pharmacol; 2013 Feb; 702(1-3):12-9. PubMed ID: 23353590
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C
Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957
[TBL] [Abstract][Full Text] [Related]
3. Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?
Kiykac Altinbas S; Tapisiz OL; Cavkaytar S; Simsek G; Oguztuzun S; Goktolga U
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():7-12. PubMed ID: 25462212
[TBL] [Abstract][Full Text] [Related]
4. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.
Becker CM; Sampson DA; Rupnick MA; Rohan RM; Efstathiou JA; Short SM; Taylor GA; Folkman J; D'Amato RJ
Fertil Steril; 2005 Oct; 84 Suppl 2():1144-55. PubMed ID: 16210006
[TBL] [Abstract][Full Text] [Related]
5. Regression of endometrial explants in a rat model of endometriosis treated with melatonin.
Güney M; Oral B; Karahan N; Mungan T
Fertil Steril; 2008 Apr; 89(4):934-42. PubMed ID: 17582405
[TBL] [Abstract][Full Text] [Related]
6. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model.
Ozcan Cenksoy P; Oktem M; Erdem O; Karakaya C; Cenksoy C; Erdem A; Guner H; Karabacak O
Gynecol Endocrinol; 2015 Mar; 31(3):219-24. PubMed ID: 25373440
[TBL] [Abstract][Full Text] [Related]
7. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
8. Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis.
Abbas MA; Taha MO; Disi AM; Shomaf M
Eur J Pharmacol; 2013 Sep; 715(1-3):72-5. PubMed ID: 23810684
[TBL] [Abstract][Full Text] [Related]
9. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?
Bayoglu Tekin Y; Guven S; Kirbas A; Kalkan Y; Tumkaya L; Guvendag Guven ES
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():1-6. PubMed ID: 25462211
[TBL] [Abstract][Full Text] [Related]
10. Clotrimazole is effective for the regression of endometriotic implants in a Wistar rat experimental model of endometriosis.
Machado DE; Perini JA; de Mendonça EM; Branco JR; Rodrigues-Baptista KC; Alessandra-Perini J; Espíndola-Netto JM; Dos Santos TA; Coelho WS; Nasciutti LE; Sola-Penna M; Zancan P
Mol Cell Endocrinol; 2018 Nov; 476():17-26. PubMed ID: 29689297
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.
García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R
Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642
[TBL] [Abstract][Full Text] [Related]
12. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats.
Ergenoğlu AM; Yeniel AÖ; Erbaş O; Aktuğ H; Yildirim N; Ulukuş M; Taskiran D
Reprod Sci; 2013 Oct; 20(10):1230-6. PubMed ID: 23536571
[TBL] [Abstract][Full Text] [Related]
13. Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
Vlahos NF; Gregoriou O; Deliveliotou A; Perrea D; Vlachos A; Zhao Y; Lai J; Creatsas G
Fertil Steril; 2010 Mar; 93(4):1316-23. PubMed ID: 19147132
[TBL] [Abstract][Full Text] [Related]
14. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
15. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
18. Studies on the surgical induction of endometriosis in the rat.
Vernon MW; Wilson EA
Fertil Steril; 1985 Nov; 44(5):684-94. PubMed ID: 4054348
[TBL] [Abstract][Full Text] [Related]
19. Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy.
Pittatore G; Moggio A; Benedetto C; Bussolati B; Revelli A
Reprod Sci; 2014 Mar; 21(3):296-304. PubMed ID: 24037753
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
